Clinical evaluation and monitoring of lupus kidney disease

Lupus

Volumn 7, Issue 9, 1998, Pages 618-621

  Austin, H A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Glomerular filtration rate; Kidney function tests; Lupus nephritis; Proteinuria

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DNA ANTIBODY; PROTEIN;

CLINICAL FEATURE; COMPLEMENT BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICAL ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; REVIEW; SEROLOGY; URINALYSIS;

HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS;

EID: 0032414815     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920749     Document Type: Review

References (28)

1. Domoto DT et al. The significance of electron dense deposits in mild lupus nephritis. Yale Journal of Biology and Medicine 1980; 53: 317-324.
2. Golbus J, McCune WJ. Lupus nephritis. Classification, prognosis, immunopathogenesis and treatment. Rheum Dis Clin North Am 1994; 20: 213-242.
3. Hebert LA et al. Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus. Am J Kidney Dis 1995; 26: 432-438.
4. Wallace DJ et al. Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980. Am J Med 1982; 72: 209-220.
5. Donadio JV Jr, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 1995; 4: 109-115.
6. Austin HA, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 1995; 10: 1620-1628.
7. Moroni G et al. 'Nephritic flares' are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 1996; 50: 2047-2053.
8. Fraenkel L et al. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis. J Rheumatol 1994; 21: 2052-2057.
9. Rodby RA et al. The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type I diabetic patients with nephropathy: The Collaborative Study Group. Am J Kidney Dis 1995; 26: 904-909.
10. Deen WM, Satvat B, Jamieson JM. Theoretical model for glomerular filtration of charged solutes. Am J Physiol 1980; 238: F126-F139.
11. Friedman S et al. Glomerular capillary wall function in human lupus nephritis. Am J Physiol 1984; 246: F580-F591.
12. Shemesh O, Golbetz H, Kriss JP, Myers DB. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28: 830-838.
13. Bauer JH, Brooks CS, Burch RN. Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 1982; 2: 337-346.
14. Zaltzman JS et al. Accurate measurement of impaired glomerular filtration using single-dose oral cimetidine. Am J Kidney Dis 1996; 27: 504-511.
15. Roubenoff R et al. Oral cimetidine improves the accuracy and precision of creatinine clearance in lupus nephritis. Ann Intern Med 1990; 113: 501-506.
16. Lafayette RA, Perrone RD, Levey AS. Laboratory evaluation of renal function. In: Schrier RW, Gottschalk CW (eds) Diseases of the Kidney. Little, Brown: Boston, 1997, pp 307-354.
17. Wilson CB, Blantz RC. Nephroimmunopathology and pathophysiology. Am J Physiol 1985; 248: F319-F331.
18. Kimberly RP et al. Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus. Ann Intern Med 1978; 89: 336-341.
19. Kimberly RP, Bowden RE, Keiser HR, Plotz PH. Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med 1978; 64: 804-807.
20. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-1666.
21. Hill GS, Hinglais N, Tron F, Bach J. Systemic lupus erythematosus: morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med 1978; 64: 61-79.
22. Pillemer SR, Austin HA, Tsokos GC, Balow JE. Lupus nephritis: association between serology and renal biopsy measures. J Rheumatol 1988; 15: 284-288.
23. Siegert CEH et al. Predictive value of IgG autoantibodies against CIq for nephritis in systemic lupus erythematosus. Ann Rheum Dis 1993; 52: 851-856.
24. Coremans IEM et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 1995; 26: 595-601.
25. Laitman RS et al. Effect of long-term normalization of serum complement levels on the course of lupus nephritis. Am J Med 1989; 87: 132-138.
26. ter Borg EJ et al. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum 1990; 33: 634-643.
27. Bootsma H et al. Prevention of relapses in systemic lupus erythematosus. Lancet 1995; 345: 1595-1599.
28. Walz LeBlanc BAE, Gladman DD, Urowitz MB. Serologically active clinically quiescent systemic lupus erythematosus - predictors of clinical flares. J Rheumatol 1994; 21: 2239-2241.